Religare Enterprises Limited has announced the grant of 25,998 stock options to its employees under the Religare Enterprises Limited Employee Stock Option Plan 2019. The Nomination and Remuneration Committee approved the grant on November 12, 2026. These options, each convertible into one equity share of face value ₹10, have an exercise price of ₹230.78 per share. Vesting will occur in five equal annual installments, with the first tranche scheduled after one year from the grant date.
Religare Enterprises Approves Employee Stock Options
Religare Enterprises Limited announced today that its Nomination and Remuneration Committee has approved the grant of 25,998 (Twenty-Five Thousand Nine Hundred Ninety-Eight) stock options to eligible employees. This grant is made under the company’s existing Employee Stock Option Plan 2019, referred to as the “Scheme”. The decision was made during a committee meeting held on November 12, 2026.
Key Details of the Stock Option Grant
Each stock option granted is convertible into one equity share of Religare Enterprises Limited, with a face value of ₹10 per share. The exercise price for these options has been fixed at ₹230.78 per equity share. The approval for this scheme is in line with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Vesting Schedule and Exercise Period
The stock options will be subject to a vesting schedule, comprising five equal annual installments of 20% each year. The first installment of vested options is scheduled to be available to employees upon the completion of one year from the date of the grant. Specifically, 5,199 options are slated to vest in the first through fourth years, with the remaining 5,202 options vesting in the fifth year. Employees will have the ability to exercise these vested options for a period not later than 8 years from the date of vesting.
The total number of shares covered by these options amounts to 25,998 Equity Shares.
Source: BSE
